Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors
Journal Article
Overview
publication date
- September 1, 2020
has subject area
has restriction
- green
Date in CU Experts
- May 19, 2020 11:12 AM
Full Author List
- Davis SL; Ionkina AA; Bagby SM; Orth JD; Gittleman B; Marcus JM; Lam ET; Corr BR; O'Bryant CL; Glode AE
author count
- 21
citation count
- 10
published in
- Clinical Cancer Research Journal
Other Profiles
International Standard Serial Number (ISSN)
- 1078-0432
Electronic International Standard Serial Number (EISSN)
- 1557-3265
Digital Object Identifier (DOI)
Additional Document Info
start page
- 4633
end page
- 4642
volume
- 26
issue
- 17